Browse > Article

Development of an Enzyme-Linked Immunosorbent Assay Method for Residual Host Cell derived Proteins in Recombinant Antibody Drug Production  

Joung, Chan-Hi (Department of Biological Engineering, Inha University)
Lim, Sang-Min (Department of Biological Engineering, Inha University)
Koo, Yoon-Mo (Department of Biological Engineering, Inha University)
Lee, Yong-Yoon (ISU ABXIS Co. Ltd.)
Son, Young-Su (ISU ABXIS Co. Ltd.)
Kim, Hyun-Il (ISU ABXIS Co. Ltd.)
Park, Heung-Rok (ISU ABXIS Co. Ltd.)
Publication Information
KSBB Journal / v.21, no.3, 2006 , pp. 212-219 More about this Journal
Abstract
The purpose of this study was to develop a assay system of host cell-derived residual proteins in final pharmaceutical products. Accurate and simple assay system for host cell-derived proteins(HCPs) is very important test item in pharmaceutical qualification control. In this study, methods for quantification of residual HCPs in recombinant anti-GPIIbIIIa antibody were developed using a process-specific immunoligand assay which was based on the Enzyme linked Immunosorbent assay(ELISA) system. The assay had a detection limit of 10.8 ng/ml of HCPs with a product concentration of 1 mg/ml. The practical implication of these results is that the developed ELISA system can be used for HCPs qualification control and this system will be applicable to develop another ELISA system of different antibody drug.
Keywords
Host cell derived proteins; ELISA system; anti-GPIIbIIIa antibody;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Briggs, J., V. T. Kung, B. Gomez, K. C. Kasper, P. A. Nagainis, R. S. Masino, L. S. Rice, R. F. Zuk and V. E. Ghazarossian (1990), Sub-femtomole quantitation of proteins with Threshold for the biophamaceutical industry, Biotechniques 9, 598-606
2 Robey, F. A.(1986), In Methods in Protein Sequence Analysis, K. A. Walsh Eds.: Human Press, Clifton, NJ, pp67-78
3 Anicetti, V. R., E. F. Fehskens, B. R. Reed, A. B. Chen, P. Moore, M. D. Geier and A. J. Jones (1986), Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone, J. Immunol. Methods 91, 213-224   DOI   ScienceOn
4 Eaton, L. C. (1995), Host cell contaminant protein assay development for recombinant biopharmaceuticals, J. Chromatogr. A 705, 105-114   DOI   ScienceOn
5 Garg, V. K., M. A. Costello, and B. A. Czuba (1991), Purification and production of therapeutic grade proteins, Bioprocess Technol. 12, 29-54
6 Nicholson, I. C., X. Zou, A. V. Popov, G. P. Cook, E. M. Corps, S. Humphries, C. Ayling, B. Goyenechea, J. Xian, M. J. Taussig, M. S. Neuberger and M. Bruggemann (1999), Antibody repertoires of four- and five-feature translicus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes, J. Immunol. 163, 6898-6906
7 Jones, A. J. and J. V. O'Connor (1985), Control of recombinant DNA produced pharmaceuticals by a combination of process validation and final product specifications, Dev. Biol. Stand. 59, 175-180
8 Himanen, J. P., M. Sarvas and I. M. Helander (1993), Assessment of non-protein impurities in potential vaccine proteins produced by Bacillus subtilis, Vaccine 11, 970-973   DOI   ScienceOn
9 Kung, V. T., P. R. Panfili, E. L. Sheldon, R. S. King, P. A. Nagainis, B. Gomez, D. A. Ross, J. Briggs and R. F. Zuk (1990), Picogram quantitation of total DNA using DNA-binding proteins in a silicon sensor-based system, Anal. Biochem. 187, 220-227   DOI   ScienceOn
10 Bass, R. (1996), ICH Topic Q 2 B Validation of Analytical Procedures; Methodology, Step 4 Consensus Guidline 6, ICH-Technical Coordination
11 Eaton, L. C. (1989), Quantitation of residual Escherichia coli DNA in recombinant biopharmaceutical proteins by hybridization analysis, J. Pharm. Biomed. Anal. 7, 633-638   DOI   ScienceOn
12 Anicetti, V. R. (1990), Analytical Biotechnology: Capillary Electrophoresis and Chromatography, In ACS Symposium Series, Cs. Horvath and J. G. Nikelly Eds: American Chemical Society, Washington DC. No. 434, 127-140
13 Anicetti, V. R., B. A. Keyt and W. S. Hancock (1989), Purity analysis of protein pharmaceuticals produced by recombinant DNA technology, Trends. Biotechnol. 7, 342-349   DOI   ScienceOn
14 Lucas, C., C. Nelson, M. L. Peterson, S. Fire, D. Vetterlein, T. Gregory and A. B. Chen (1998), Enzyme-linked immunosorbent assays (ELISAs) for the determination of contaminants resulting from the immunoaffinity purification of recombinant proteins, J. Immunol. Methods 113, 113-122   DOI   ScienceOn